Private Equity • Life Science R&D Facilities • 51-200 employees • Los Angeles, CA
Breakthrough Properties is a joint venture real estate firm established in 2019 by Tishman Speyer and Bellco Capital, specializing in life science research and development real estate. The firm develops, owns, and operates specialized R&D facilities for biotechnology, pharmaceutical, and academic research clients. It raised $3 billion through the Breakthrough Life Science Property Fund, the largest dedicated fund to life sciences real estate at its final close in 2022. Its portfolio includes more than 6 million square feet across the United States and Europe, housing tenants such as AstraZeneca, Pfizer, CRISPR Therapeutics, and Genentech. Candidates working at Breakthrough Properties may gain experience in life science campus development, lab facilities management, and office-to-lab conversions, reflecting emerging real estate asset specialization. This firm offers exposure to niche real estate investment and development within the high-growth life science sector, relevant for candidates targeting specialized CRE roles in technology-driven property segments.
Unlock review detail and work-life signals.
Interview Reports
0
Interview Questions
0
Comp ReportsCompensation Reports
0
Workplace Reports
0
Sign up to keep researching firm details.
Unlock comp reports and firm-level pay benchmarks.
Sign up to keep researching firm details.
Unlock interview questions and process notes.
Sign up to keep researching firm details.